- Home
- KGS vs CPRX Comparison
KGS vs CPRX Comparison
Compare KGS & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGS
- CPRX
- Stock Information
- Founded
- KGS 2011
- CPRX 2002
- Country
- KGS United States
- CPRX United States
- Employees
- KGS N/A
- CPRX 167
- Industry
- KGS
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- KGS
- CPRX Health Care
- Exchange
- KGS Nasdaq
- CPRX Nasdaq
- Market Cap
- KGS 2.8B
- CPRX 2.6B
- IPO Year
- KGS 2023
- CPRX 2006
- Fundamental
- Price
- KGS $31.32
- CPRX $21.12
- Analyst Decision
- KGS Strong Buy
- CPRX Strong Buy
- Analyst Count
- KGS 10
- CPRX 6
- Target Price
- KGS $41.20
- CPRX $32.83
- AVG Volume (30 Days)
- KGS 1.1M
- CPRX 1.3M
- Earning Date
- KGS 08-11-2025
- CPRX 08-06-2025
- Dividend Yield
- KGS 5.75%
- CPRX N/A
- EPS Growth
- KGS N/A
- CPRX 178.13
- EPS
- KGS 0.54
- CPRX 1.57
- Revenue
- KGS $1,273,461,000.00
- CPRX $534,645,999.00
- Revenue This Year
- KGS $16.97
- CPRX $16.37
- Revenue Next Year
- KGS $6.27
- CPRX $8.80
- P/E Ratio
- KGS $58.15
- CPRX $13.47
- Revenue Growth
- KGS 45.41
- CPRX 29.97
- 52 Week Low
- KGS $24.84
- CPRX $15.34
- 52 Week High
- KGS $50.43
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- KGS 41.09
- CPRX 43.70
- Support Level
- KGS $31.49
- CPRX $20.76
- Resistance Level
- KGS $32.43
- CPRX $21.71
- Average True Range (ATR)
- KGS 0.84
- CPRX 0.59
- MACD
- KGS 0.09
- CPRX 0.10
- Stochastic Oscillator
- KGS 25.65
- CPRX 44.07
About KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).